These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15191617)

  • 1. Three year naturalistic outcome study of panic disorder patients treated with paroxetine.
    Dannon PN; Iancu I; Cohen A; Lowengrub K; Grunhaus L; Kotler M
    BMC Psychiatry; 2004 Jun; 4():16. PubMed ID: 15191617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
    Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
    Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
    Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
    Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants.
    Toni C; Perugi G; Frare F; Mata B; Vitale B; Mengali F; Recchia M; Serra G; Akiskal HS
    Pharmacopsychiatry; 2000 Jul; 33(4):121-31. PubMed ID: 10958260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.
    Pollack M; Mangano R; Entsuah R; Tzanis E; Simon NM; Zhang Y
    Psychopharmacology (Berl); 2007 Oct; 194(2):233-42. PubMed ID: 17589833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y; Judge R
    Acta Psychiatr Scand; 1997 Feb; 95(2):153-60. PubMed ID: 9065681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine.
    Nardi AE; Freire RC; Mochcovitch MD; Amrein R; Levitan MN; King AL; Valença AM; Veras AB; Paes F; Sardinha A; Nascimento I; de-Melo-Neto VL; Dias GP; E Silva AC; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    J Clin Psychopharmacol; 2012 Feb; 32(1):120-6. PubMed ID: 22198456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.
    Sheehan DV; Burnham DB; Iyengar MK; Perera P;
    J Clin Psychiatry; 2005 Jan; 66(1):34-40. PubMed ID: 15669886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
    Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
    J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow vs standard up-titration of paroxetine in the treatment of panic disorder: a prospective randomized trial.
    Buoli M; Dell'osso B; Bosi MF; Altamura C
    Psychiatry Clin Neurosci; 2010 Dec; 64(6):612-9. PubMed ID: 21040188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.
    Kampman M; Keijsers GP; Hoogduin CA; Hendriks GJ
    J Clin Psychiatry; 2002 Sep; 63(9):772-7. PubMed ID: 12363116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.
    Marchesi C; Cantoni A; Fontò S; Giannelli MR; Maggini C
    Pharmacopsychiatry; 2006 Mar; 39(2):60-5. PubMed ID: 16555166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine.
    Nardi AE; Valença AM; Freire RC; Mochcovitch MD; Amrein R; Sardinha A; Levitan MN; Nascimento I; de-Melo-Neto VL; King AL; de O E Silva AC; Veras AB; Dias GP; Soares-Filho GL; da Costa RT; Mezzasalma MA; de Carvalho MR; de Cerqueira AC; Hallak JE; Crippa JA; Versiani M
    Braz J Med Biol Res; 2011 Apr; 44(4):366-73. PubMed ID: 21344132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia.
    Fava GA; Bernardi M; Tomba E; Rafanelli C
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):835-8. PubMed ID: 17224089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.
    Bell C; Forshall S; Adrover M; Nash J; Hood S; Argyropoulos S; Rich A; Nutt DJ
    J Psychopharmacol; 2002 Mar; 16(1):5-14. PubMed ID: 11949771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.
    Bandelow B; Behnke K; Lenoir S; Hendriks GJ; Alkin T; Goebel C; Clary CM
    J Clin Psychiatry; 2004 Mar; 65(3):405-13. PubMed ID: 15096081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxetine in panic disorder: clinical management and long-term follow-up.
    Dannon PN; Lowengrub K; Iancu I; Kotler M
    Expert Rev Neurother; 2004 Mar; 4(2):191-8. PubMed ID: 15853560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.